Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Verantos
company
About
Verantos is the market leader in high-validity real-world evidence at scale for life sciences.
- 51 - 100
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $224.79K
- Industries
- Artificial Intelligence,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2013
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Verantos is the market leader in high-validity real-world evidence for life sciences. By incorporating robust clinical narrative data, artificial intelligence technology, and measured validity, Verantos is the first company to generate research-grade evidence at scale across all therapeutic areas. The Verantos Evidence Platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for market access, HEOR, medical affairs, and regulatory use.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.42M
Verantos has raised a total of
$1.42M
in funding over 2 rounds. Their latest funding was raised on
Dec 20, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 20, 2020 | Grant | $1.19M | 1 |
National Science Foundation
|
— | Detail |
| Jun 25, 2018 | Grant | $224.79K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Verantos is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
